Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients

Hafsah Nabi*, Rikke Ibsen, Michael Ibsen, Jakob Kjellberg, Merete Lund Hetland, Bente Glintborg

*Corresponding author af dette arbejde

Fingeraftryk

Dyk ned i forskningsemnerne om 'Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry